Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients

References

• BousfihaA, PicardC, Boisson-DupuisS, ZhangSY, BustamanteJ, PuelA, JouanguyE, AilalF, El-BaghdadiJ, AbelL, et al. Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol2010; 135:204 - 9; http://dx.doi.org/10.1016/j.clim.2010.02.001; PMID: 20236864
   PubMedGoogle Scholar
• FioreAE, ShayDK, BroderK, IskanderJK, UyekiTM, MootreyG, BreseeJS, CoxNS, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep2008; 57:RR-71 - 60; PMID: 18685555
   PubMedGoogle Scholar
• MossWJ, ClementsCJ, HalseyNA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ2003; 81:61 - 70; PMID: 12640478
   PubMed Web of Science ®Google Scholar
• LevinMJ. Varicella vaccination of immunocompromised children. J Infect Dis2008; 197:Suppl 2S200 - 6; http://dx.doi.org/10.1086/522133; PMID: 18419398
   PubMed Web of Science ®Google Scholar
• MensonEN, MelladoMJ, BamfordA, CastelliG, DuiculescuD, MarczyńskaM, NavarroM, ScherpbierHJ, HeathPT, Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group, PENTA Steering Committee, Children’s HIV Association (CHIVA). Guidance on vaccination of HIV-infected children in Europe. HIV Med2012; 13:333 - 6, e1-14; http://dx.doi.org/10.1111/j.1468-1293.2011.00982.x; PMID: 22296225
   PubMed Web of Science ®Google Scholar
• RubinLG, LevinMJ, LjungmanP, DaviesEG, AveryR, TomblynM, BousvarosA, DhanireddyS, SungL, KeyserlingH, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis2014; 58:309 - 18; http://dx.doi.org/10.1093/cid/cit816; PMID: 24421306
   PubMed Web of Science ®Google Scholar
• Italian Ministry of Health. Piano Nazionale in Prevenzione Vaccinale 2012-14. Available at: http://www.salute.gov.it/imgs/c_17_pubblicazioni_1721_allegato.pdf (accessed on 06/07/2014)
   Google Scholar
• Italian Ministry of Health. Linee Guida Italiane sull’utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1 (November 2013). Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2074_allegato.pdf (accessed on 06/07/2014)
   Google Scholar
• GerettiAM, DoyleT. Immunization for HIV-positive individuals. Curr Opin Infect Dis2010; 23:32 - 8; http://dx.doi.org/10.1097/QCO.0b013e328334fec4; PMID: 19949327
   PubMed Web of Science ®Google Scholar
• MyersC, Posfay-BarbeKM, AebiC, CheseauxJJ, KindC, RudinC, NadalD, SiegristCA, Pediatric Infectious Disease Group of Switzerland (PIGS), Swiss Mother and Child HIV Cohort Study (MoCHIV). Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J2009; 28:996 - 1001; http://dx.doi.org/10.1097/INF.0b013e3181a78348; PMID: 19820427
   PubMedGoogle Scholar
• Fernández-IbietaM, Ramos-AmadorJT, Auñón-MartínI. HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study. Int J STD AIDS2007; 18:351 - 3; http://dx.doi.org/10.1258/095646207780749763; PMID: 17524201
   PubMedGoogle Scholar
• BamfordA, CunningtonA, DanielsJ, MensonE, LyallH, KampmannB, et al. Immunisation status of children with HIV: failure to protect a vulnerable population. 27th Annual Meeting of the European Society for Paediatric Infectious Disease. Brussels, Belgium, June 2009. [Abstract P227]Pediatr Infect Dis J2009; 28:e79
   PubMedGoogle Scholar
• CagigiA, CotugnoN, GiaquintoC, NicolosiL, BernardiS, RossiP, DouagiI, PalmaP. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions. Hum Vaccin Immunother2012; 8:1784 - 94; http://dx.doi.org/10.4161/hv.21827; PMID: 22906931
   PubMed Web of Science ®Google Scholar
• PlotkinSA. Correlates of protection induced by vaccination. Clin Vaccine Immunol2010; 17:1055 - 65; http://dx.doi.org/10.1128/CVI.00131-10; PMID: 20463105
   PubMed Web of Science ®Google Scholar
• World Health Organization. Polio laboratoty manual. 4th Edition.2004. Geneva, Switzerland.
   Google Scholar
• HerremansMM, ReimerinkJH, RasA, Van Der AvoortHG, KimmanTG, Van LoonAM, Conyn-Van SpaendonckMA, KoopmansMP. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test. Clin Diagn Lab Immunol1997; 4:659 - 64; PMID: 9384285
   PubMedGoogle Scholar
• PandolfiE, CarloniE, MarinoMG, Ciofi degli AttiML, GesualdoF, RomanoM, GiannattasioA, GuarinoA, CarloniR, BorgiaP, et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine2012; 30:5172 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.02.099; PMID: 21414380
   PubMed Web of Science ®Google Scholar
• MphahleleMJ, MdaS. Immunising the HIV-infected child: a view from sub-Saharan Africa. Vaccine2012; 30:Suppl 3C61 - 5; http://dx.doi.org/10.1016/j.vaccine.2012.02.040; PMID: 22939024
   PubMedGoogle Scholar
• MossWJ, ClementsCJ, HalseyNA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ2003; 81:61 - 70; PMID: 12640478
   PubMed Web of Science ®Google Scholar
• PensierosoS, CagigiA, PalmaP, NilssonA, CapponiC, FredaE, BernardiS, ThorstenssonR, ChiodiF, RossiP. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci U S A2009; 106:7939 - 44; http://dx.doi.org/10.1073/pnas.0901702106; PMID: 19416836
   PubMed Web of Science ®Google Scholar
• MoirS, BucknerCM, HoJ, WangW, ChenJ, WaldnerAJ, PosadaJG, KardavaL, O’SheaMA, KottililS, et al. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood2010; 116:5571 - 9; http://dx.doi.org/10.1182/blood-2010-05-285528; PMID: 20837780
   PubMed Web of Science ®Google Scholar
• An earlier start for HIV therapy. Nat Med2009; 15:848; http://dx.doi.org/10.1038/nm0809-848; PMID: 19661988
   PubMedGoogle Scholar
• SiriaksornS, PuthanakitT, SirisanthanaT, SirisanthanaV. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine2006; 24:3095 - 9; http://dx.doi.org/10.1016/j.vaccine.2006.01.045; PMID: 16488516
   PubMed Web of Science ®Google Scholar
• BekkerV, ScherpbierH, PajkrtD, JurriaansS, ZaaijerH, KuijpersTW. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics2006; 118:e315 - 22; http://dx.doi.org/10.1542/peds.2005-2616; PMID: 16847077
   PubMed Web of Science ®Google Scholar
• AbzugMJ, SongLY, FentonT, NachmanSA, LevinMJ, RosenblattHM, PeltonSI, BorkowskyW, EdwardsKM, PetersJ, International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 Protocol Team. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics2007; 120:e1190 - 202; http://dx.doi.org/10.1542/peds.2007-0729; PMID: 17938165
   PubMed Web of Science ®Google Scholar
• MadhiSA, KlugmanKP, KuwandaL, CutlandC, KäyhtyH, AdrianP. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis2009; 199:1168 - 76; http://dx.doi.org/10.1086/597388; PMID: 19265481
   PubMed Web of Science ®Google Scholar
• ThakurA, PedersenLE, JungersenG. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine2012; 30:4907 - 20; http://dx.doi.org/10.1016/j.vaccine.2012.05.049; PMID: 22658928
   PubMed Web of Science ®Google Scholar
• TejiokemMC, GouandjikaI, BéniguelL, ZangaMC, TeneG, GodyJC, NjamkepoE, KfutwahA, PendaI, BilongC, et al. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. PLoS One2007; 2:e1260; http://dx.doi.org/10.1371/journal.pone.0001260; PMID: 18060056
   PubMedGoogle Scholar
• SutterRW, SuleimanAJ, MalankarP, Al-KhusaibyS, MehtaF, ClementsGB, PallanschMA, RobertsonSE. Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med2000; 343:767 - 73; http://dx.doi.org/10.1056/NEJM200009143431103; PMID: 10984564
   PubMed Web of Science ®Google Scholar
• TrikiH, AbdallahMV, Ben AissaR, BouratbineA, Ben Ali KacemM, BouraouiS, KoubaaC, ZouariS, MohsniE, CrainicR, et al. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine1997; 15:1123 - 9; http://dx.doi.org/10.1016/S0264-410X(97)00001-7; PMID: 9269056
   PubMedGoogle Scholar